Asthma Clinical Trials in Cincinnati, Ohio

7 studies are recruiting for asthma in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

   To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled corticosteroids (ICS) and at least one additional asthma controller medication with or without oral corticosteroids.

   Stage

   Phase 3

   Ages

   5 to 11

   Site

   Research Site, Cincinnati, Ohio

   Locations

   147 in total

   Run by

   AstraZeneca

   See if you can join NCT06023589 on ClinicalTrials.gov

2. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

   The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   GSK Investigational Site, Cincinnati, Ohio

   Locations

   67 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT05757102 on ClinicalTrials.gov

3. A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

   The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

   Stage

   Phase 2

   Ages

   4 to 11

   Site

   Research Site, Cincinnati, Ohio

   Locations

   43 in total

   Run by

   AstraZeneca

   See if you can join NCT07525375 on ClinicalTrials.gov

4. Registry of Asthma Characterization and Recruitment 3 (RACR3)

   This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

   Stage

   Not phased

   Ages

   Any age

   Site

   Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati, Ohio

   Locations

   7 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT05272241 on ClinicalTrials.gov

5. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Cincinnati, Ohio

   Locations

   150 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

6. SMART@Home Feasibility Trial

   The proposed research addresses the limitations or lack of a digital platform to provide remote care of medically complex patients. Previous attempts have had poor clinical validity and suffered lack of patient engagement. The study team will deconstruct the previously implemented SMART platforms t…

   Stage

   Not phased

   Ages

   12 to 18

   Site

   Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT06159127 on ClinicalTrials.gov

7. Protocol CAUSE-03 / CHEETAH

   This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot h…

   Stage

   Not phased

   Ages

   6 to 17

   Site

   Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati, Ohio

   Locations

   8 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT06136091 on ClinicalTrials.gov